United Therapeutics (UTHR)
(Delayed Data from NSDQ)
$327.79 USD
+14.50 (4.63%)
Updated Aug 1, 2024 04:00 PM ET
After-Market: $327.52 -0.27 (-0.08%) 7:58 PM ET
1-Strong Buy of 5 1
B Value B Growth B Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: -- |
9/2024 | $6.60 | -0.47% |
Earnings Summary
For their last quarter, United Therapeutics (UTHR) reported earnings of $5.85 per share, missing the Zacks Consensus Estimate of $6.33 per share. This reflects a negative earnings surprise of 7.58%. Look out for UTHR's next earnings release expected on November 06, 2024. For the next earning release, we expect the company to report earnings of $6.60 per share, reflecting a year-over-year increase of 22.68%.
Earnings History
Price & Consensus
Zacks News for UTHR
Sage Therapeutics (SAGE) Q2 Loss Wider Than Expected, Sales Rise
UTHR: What are Zacks experts saying now?
Zacks Private Portfolio Services